Lee Ainslie - Maverick Capital Ltd
Holding/activity history for DexCom, Inc. (DXCM)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 0.04 | SEC | ||
| 2024 Q2 | 16,664 | 0.04 | Buy | 0.04 | $113.38 | $1,889,364 | SEC |
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2023 Q4 | 4,876 | 0.01 | Reduce 58.54% | 0.01 | $124.09 | $605,063 | SEC |
| 2023 Q3 | 11,761 | 0.02 | Buy | 0.02 | $93.30 | $1,097,301 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q2 | 211 | <0.01 | Reduce 92.82% | <0.01 | $426.54 | $90,000 | SEC |
| 2021 Q1 | 2,939 | 0.01 | Add 1,021.76% | <0.01 | $359.31 | $1,056,000 | SEC |
| 2020 Q4 | 262 | <0.01 | Reduce 27.62% | <0.01 | $370.23 | $97,000 | SEC |
| 2020 Q3 | 362 | <0.01 | Buy | <0.01 | $411.60 | $149,000 | SEC |